MAJI (Exousia Pro) EBIT: $-0.52 Mil (TTM As of Jan. 2021)


What is Exousia Pro EBIT?

Exousia Pro MAJI +5.90% EBIT is $-0.52 Mil as of Jan. 2021.

Exousia Pro's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2021 was $-0.13 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2021 was $-0.52 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Exousia Pro's annualized ROC % for the quarter that ended in Jan. 2021 was -217.00%. Exousia Pro's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2021 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Exousia Pro's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2021 was -95.60%.

Exousia Pro  (OTCPK:MAJI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Exousia Pro's annualized ROC % for the quarter that ended in Jan. 2021 is calculated as:

ROC % (Q: Jan. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2020 ) + Invested Capital (Q: Jan. 2021 ))/ count )
=-0.536 * ( 1 - 0% )/( (0.247 + 0.247)/ 2 )
=-0.536/0.247
=-217.00 %

where

Invested Capital(Q: Oct. 2020 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.019 - 0.198 - ( 0.019 - max(0, 0.445 - 0.019+0.019))
=0.247

Invested Capital(Q: Jan. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0.198 - ( 0 - max(0, 0.445 - 0+0))
=0.247

Note: The Operating Income data used here is four times the quarterly (Jan. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

Exousia Pro's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2021 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2021 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2020  Q: Jan. 2021
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.536/( ( (0 + max(-0.198, 0)) + (0 + max(-0.198, 0)) )/ 1 )
=-0.536/( ( 0 + 0 )/ 1 )
=-0.536/0
= %

where Working Capital is:

Working Capital(Q: Oct. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.198 + 0 + 0)
=-0.198

Working Capital(Q: Jan. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.198 + 0 + 0)
=-0.198

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2021) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Exousia Pro's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2021 )
=-0.521/0.545
=-95.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro EBIT Related Terms

Exousia Pro EBIT Historical Data

* Premium members only.

The historical data trend for Exousia Pro's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro EBIT Chart

Exousia Pro Annual Data
Trend Apr11 Apr12 Apr18 Apr19
EBIT
-0.10 -5.99 -0.00 -0.13

Exousia Pro Quarterly Data
Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.14 -0.06 -0.19 -0.13

MAJI vs HCCH, GRNV, AGBA: EBIT Comparison

For the Biotechnology subindustry, Exousia Pro's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exousia Pro EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exousia Pro's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Exousia Pro's EV-to-EBIT falls into.


Exousia Pro EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-0.52 Mil mean?
Exousia Pro (MAJI) has a EBIT of $-0.52 Mil as of Jan. 2021. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Exousia Pro.
Is Exousia Pro's EBIT too high?
Exousia Pro's current EBIT is $-0.52 Mil.
How does Exousia Pro's EBIT compare to HCCH and GRNV?
Exousia Pro's EBIT of $-0.52 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Exousia Pro. Exousia Pro's current EBIT is $-0.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exousia Pro stock overvalued right now?
Exousia Pro (MAJI) has a current EBIT of $-0.52 Mil. The current EBIT is $-0.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Exousia Pro (MAJI), the current EBIT is $-0.52 Mil as of Jan. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exousia Pro Business Description

Address 7901 4th Street North, No. 23494, St. Petersburg, FL, USA, 33702
Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.